Rx Communications

If your research isn’t discoverable, it won’t make an impact. Before submitting, check whether the journal is indexed in PubMed, Scopus, Web of Science and DOAJ. For more tips on boosting discoverability, check out our ultimate guide to selecting a journal for publication! https://lnkd.in/g_e2w3k6

Rx Communications is celebrating 25 years of transforming science into story. From clinical data to meaningful dialogue, we’ve been helping research make a real-world impact since 2000. What have we learned along the way — and where is MedComms heading next? Read the anniversary edition of our newsletter: https://lnkd.in/g7jqncGy

A major milestone for rare disease treatment. The FDA has approved Kygevvi, the first ever medication for thymidine kinase 2 deficiency (TK2d), a devastating mitochondrial disorder that affects muscle strength and respiratory function. TK2d has long been a diagnosis without options. Now, clinical data show Kygevvi can reduce mortality from 36% to just 4%, and almost double average survival to 9.6 years. This approval is more than a regulatory success. It is progress for a patient community that has faced limited awareness, delayed diagnoses, and no targeted treatment for far too long. Read the full story: https://lnkd.in/giZFUNRK

If a journal guarantees acceptance or promises peer review in days, it’s a warning, not a selling point. Predatory publishers are getting smarter, and even experienced researchers are being caught out. Learn how to spot the impostors, verify journal legitimacy, and keep your research in the right hands — with our in-depth guide for authors and publications teams: https://lnkd.in/dJbuHeT9

Behind every “no” from a journal is valuable insight waiting to be used. The most successful authors aren’t those who never get rejected, they’re the ones who know how to recover, revise, and resubmit. Discover how to handle reviewer comments, refine your manuscript, and choose the right journal for your next submission with expert guidance from Rx Communications: https://lnkd.in/gcsdEWSR #ResearchPublishing #MedicalWriting #PublicationStrategy #AcademicSuccess

Lung cancer causes more deaths than breast, prostate, and colon cancer combined. This November, during Lung Cancer Awareness Month, we recognise both the progress achieved and the work still ahead. Advances in screening, immunotherapy, and precision medicine are changing outcomes, yet lung cancer continues to claim more lives than any other cancer worldwide. For publications and medical affairs professionals, this month is more than a campaign, it’s a reminder of the role we play in turning data into understanding, and research into real-world impact. Every abstract, poster, and publication is an opportunity to bring innovation closer to patients. Let’s use this month to celebrate progress, share knowledge, and keep communication at the heart of improving health outcomes in lung cancer. Read more in our latest Health Outcomes Communicator: https://lnkd.in/gdmzhAmc #LungCancerAwarenessMonth #Oncology #MedicalAffairs #Publications #HealthOutcomes #MedComms

Since 2000, our mission has been the same: to bring data to life. This month, we celebrate 25 years of Rx Communications and look ahead to the next chapter in MedComms. The newsletter is available now: https://lnkd.in/g7jqncGy

There’s no cure for Alzheimer’s disease, but there is still hope. Research shows that everyday choices around sleep, diet, exercise, and stress can influence brain ageing and resilience. Learn how science is reshaping what we know about prevention and discover 10 actions that may help protect your brain for the future. https://lnkd.in/gj_2yd9H #AlzheimersResearch #BrainHealth #HealthOutcomes #MedComms

Bowel cancer isn’t just a disease of older adults. Rising rates among people under 50 are rewriting what we thought we knew  and reminding us that early detection saves lives. Read the article: https://lnkd.in/gDVHjNxS #BowelCancer #Oncology #HealthOutcomes

This month, Rx Communications celebrates 25 years in MedComms. In our latest newsletter, we look back at what has shaped us and forward to what will define the next era of scientific communication. Read more in the November issue: https://lnkd.in/g7jqncGy